Lisa Massmanian
Nessuna posizione attualmente
Storia della carriera di Lisa Massmanian
Precedenti posizioni note di Lisa Massmanian
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
| IMMUNOGEN, INC. | Corporate Officer/Principal | - | - |
| CURIS, INC. | Direttore operativo | 01/04/2015 | - |
Formazione di Lisa Massmanian
| Northeastern University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Lisa Massmanian
- Esperienza
